Malakoff, France

Claude Bernard

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Claude Bernard: Innovator in Autoimmune Research

Introduction

Claude Bernard is a notable inventor based in Malakoff, France. He has made significant contributions to the field of medical research, particularly in the treatment of autoimmune and inflammatory disorders. With a total of 4 patents, Bernard's work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on the use of low dose interleukin-2 for treating autoimmune-related or inflammatory disorders. This invention relates to novel therapies aimed at treating autoimmune and inflammatory diseases. Specifically, it addresses the use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases. This innovative approach could pave the way for new treatment options in the medical field.

Career Highlights

Throughout his career, Claude Bernard has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Assistance Publique-Hôpitaux de Paris. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Bernard has collaborated with notable colleagues, including David Klatzmann and David Saadoun. These partnerships have further enriched his research and innovation in the field of autoimmune disorders.

Conclusion

Claude Bernard's contributions to medical research, particularly in the treatment of autoimmune diseases, highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…